MiR-34a Targeting of Notch Ligand Delta-Like 1 Impairs CD15+/CD133+ Tumor-Propagating Cells and Supports Neural Differentiation in Medulloblastoma-Reference-Cited by-同舟云学术

MiR-34a Targeting of Notch Ligand Delta-Like 1 Impairs CD15+/CD133+ Tumor-Propagating Cells and Supports Neural Differentiation in Medulloblastoma

Published:2011-09-12 Issue:9 Volume:6 Page:e24584
ISSN:1932-6203
Container-title:PLoS ONE
language:en
Short-container-title:PLoS ONE

Author:

de Antonellis Pasqualino,Medaglia Chiara,Cusanelli Emilio,Andolfo Immacolata,Liguori Lucia,De Vita Gennaro,Carotenuto Marianeve,Bello Annamaria,Formiggini Fabio,Galeone Aldo,De Rosa Giuseppe,Virgilio Antonella,Scognamiglio Immacolata,Sciro Manuela,Basso Giuseppe,Schulte Johannes H.,Cinalli Giuseppe,Iolascon Achille,Zollo Massimo

Publisher

Public Library of Science (PLoS)

Subject

Multidisciplinary

Reference45 articles.

1. Correlative analyses of notch signaling with resveratrol-induced differentiation and apoptosis of human medulloblastoma cells.;Q Wang;Neurosci Lett,2008

2. Medulloblastoma can be initiated by deletion of Patched in lineage-restricted progenitors or stem cells.;ZJ Yang;Cancer Cell,2008

3. Medulloblastoma in childhood: new biological advances.;JR Crawford;Lancet Neurol,2007

4. The origins of medulloblastoma subtypes.;RJ Gilbertson;Annu Rev Pathol,2008

5. microRNAs as oncogenes and tumor suppressors.;B Zhang;Dev Biol,2007

Cited by 147 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. MiRNA Dysregulation in Brain Injury: An In Silico Study to Clarify the Role of a MiRNA Set;Current Neuropharmacology;2024-08-08

2. Targeting pediatric solid tumors in the new era of RNA therapeutics;Critical Reviews in Oncology/Hematology;2024-08

3. Local delivery of EGFR+NSCs-derived exosomes promotes neural regeneration post spinal cord injury via miR-34a-5p/HDAC6 pathway;Bioactive Materials;2024-03

4. Differential Signaling Pathways in Medulloblastoma: Nano-biomedicine Targeting Non-coding Epigenetics to Improve Current and Future Therapeutics;Current Pharmaceutical Design;2024-01

5. Methods of miRNA delivery and possibilities of their application in neuro-oncology;Non-coding RNA Research;2023-12